Follow-up study and response to treatment in 23 patients with Lewis–Sumner syndrome
K Viala, L Renie, T Maisonobe, A Béhin, J Neil… - Brain, 2004 - academic.oup.com
Lewis–Sumner syndrome (LSS) is a dysimmune peripheral nerve disorder, characterized by
a predominantly distal, asymmetric weakness mostly affecting the upper limbs with sensory …
a predominantly distal, asymmetric weakness mostly affecting the upper limbs with sensory …
Chronic inflammatory demyelinating polyradiculoneuropathy: search for factors associated with treatment dependence or successful withdrawal
…, E Fournier, P Bouche, JM Léger, K Viala - Journal of Neurology …, 2014 - jnnp.bmj.com
Background About 40% of responders to treatment for chronic inflammatory demyelinating
polyradiculoneuropathy (CIDP) remain treatment dependent and have a relapse if treatment …
polyradiculoneuropathy (CIDP) remain treatment dependent and have a relapse if treatment …
A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy
K Viala, T Maisonobe, T Stojkovic… - Journal of the …, 2010 - Wiley Online Library
We retrospectively analyzed 146 patients fulfilling the European Federation of Neurological
Societies and the Peripheral Nerve Society (EFNS/PNS) criteria for definite chronic …
Societies and the Peripheral Nerve Society (EFNS/PNS) criteria for definite chronic …
Placebo-controlled trial of rituximab in IgM anti-myelin–associated glycoprotein neuropathy
JM Léger, K Viala, G Nicolas, A Créange, JM Vallat… - Neurology, 2013 - AAN Enterprises
Objective: To determine whether rituximab 375 mg/m2 was efficacious in patients with
immunoglobulin M (IgM) anti-myelin–associated glycoprotein antibody demyelinating …
immunoglobulin M (IgM) anti-myelin–associated glycoprotein antibody demyelinating …
Cold extends electromyography distinction between ion channel mutations causing myotonia
E Fournier, K Viala, H Gervais… - Annals of Neurology …, 2006 - Wiley Online Library
Objective Myotonias are inherited disorders of the skeletal muscle excitability.
Nondystrophic forms are caused by mutations in genes coding for the muscle chloride or …
Nondystrophic forms are caused by mutations in genes coding for the muscle chloride or …
Non‐anti‐MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases
S Larue, F Bombelli, K Viala, J Neil… - European Journal of …, 2011 - Wiley Online Library
Background and purpose: Some patients within the spectrum of chronic inflammatory
demyelinating polyradiculoneuropathies (CIDP) have distal acquired demyelinating …
demyelinating polyradiculoneuropathies (CIDP) have distal acquired demyelinating …
Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera
…, C Tard, E Salort-Campana, A Verschueren, K Viala… - Journal of …, 2020 - Springer
Introduction IgG4 antibodies against neurofascin (Nfasc155 and Nfasc140/186), contactin
(CNTN1) and contactin-associated protein (Caspr1) are described in specific subtypes of …
(CNTN1) and contactin-associated protein (Caspr1) are described in specific subtypes of …
Motor neuron pathology in CANVAS due to RFC1 expansions
…, B Sablonnière, ML Monin, C Ewenczyk, K Viala… - Brain, 2022 - academic.oup.com
CANVAS caused by RFC1 biallelic expansions is a major cause of inherited sensory
neuronopathy. Detection of RFC1 expansion is challenging and CANVAS can be associated …
neuronopathy. Detection of RFC1 expansion is challenging and CANVAS can be associated …
Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy
…, V Potočková, N Hinds, J Cassereau, K Viala… - Brain, 2021 - academic.oup.com
Previous studies have described the clinical, serological and pathological features of
patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and …
patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and …
Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features
…, JC Antoine, C Vial, E Delmont, K Viala… - Journal of Neurology …, 2018 - jnnp.bmj.com
Objective To assess the clinicopathological and therapeutic features of patients with low (≥
1000 to< 10 000 Bühlmann Titre Units)(BTU), medium (10 000–70 000) or high (≥ 70 000) …
1000 to< 10 000 Bühlmann Titre Units)(BTU), medium (10 000–70 000) or high (≥ 70 000) …